文章名稱引用次數(shù)

• Implications of the tumor immune microenvironment for staging and therapeutics57
• SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma27
• Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy24
• Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma20
• Whole slide imaging equivalency and efficiency study: experience at a large academic center18
• Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms18
• Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling17
• DICER1 mutations are frequent in mullerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation17
• Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma16
• Nuclear beta-catenin localization and mutation of the CTNNB1 gene: a context-dependent association15